Blog Category

What is Digital Health? 
Posted on Feb 10, 2017

    We recently learned about Bayer’s Grants4Apps program. This program provides support to companies and projects involving “…novel software, hardware, technologies…contributing to improve health outcomes or pharmaceutical processes.”    Bayer is not the only company expressing an interest in digital health. Boehringer Ingelheim, GSK, Purdue, Otsuka, and Daichii-Sankyo are but a few examples of companies dedicating resources to

Is My Asset Licensable? 
Posted on Jan 27, 2017

  This is a good question…a question which lacks a simple answer without quite a bit of analysis. We audit out-licensing processes, and there are times when the answer is an outright “No.” But sometimes, the answer is “Maybe,” provided some changes are made to the process, or provided additional data and details are added

Biotech Showcase and JPM 2017: Wind, Rain, and Meetings 
Posted on Jan 18, 2017

Yeah, it rained last week in San Francisco.  But the rain did not stop untold thousands of us from gathering at the many hotels, watering holes, and coffee shops around Union Square.  How many of us are present in San Francisco every second week in January? 15,000? 20,000? It’s hard to tell, considering the number

Google Plus   Facebook   Twitter
Powered By : Supra International Inc.